Clinical Researcher—December 2022 (Volume 36, Issue 6)
CHAIR’S MESSAGE
David J. Morin, MD, FACP, CPI, FACRP, 2022 Chair of the Association Board of Trustees for ACRP
The past three years have seen a significant evolution in research with the exploration and adoption of new ways to conduct clinical trials. Once we obtain updated regulatory guidance, our profession will collaborate on developing optimal processes for these novel methods. Central to our success will be the ongoing development and retention of a competent workforce.
As a principal investigator (PI) and practicing physician for more than 30 years, I’ve seen tremendous innovation in developing new therapeutics and devices that have saved or improved the lives of countless thousands. The path of seeking approval for a New Drug Application, Biologics License Application, or Investigational Device Exemption through the U.S. Food and Drug Administration is incredibly complicated and expensive, and comes with no guarantees. Central to these efforts are human beings who volunteer to participate in the necessary research and place their trust in us. It’s a responsibility that requires a knowledgeable, experienced, and competent study team with proper supervision and guidance.
As a member of the Association Board of Trustees for ACRP for the past seven years, I’ve seen the commitment made by this organization to be a leader in the development of a diverse and competent workforce. Many noteworthy efforts have been made, and will continue to be made, to provide resources for professional growth at the individual and institutional levels by your Association.
For example, with clinical research roles yet to be recognized by the Bureau of Labor Statistics, ACRP certification is a great way to demonstrate knowledge and competence. As a PI, I’m more comfortable knowing that members of my study team are certified by an Association with the highest standards. While certification represents a milestone in one’s career, it only happens with a personal commitment to prepare through study and experience. It also sets the stage for maintaining that recognition through educational resources offered by ACRP.
As 2022 comes to a close and my tenure as Chair ends, it’s exciting to look back at how ACRP continues to adapt and meet or exceed the needs and expectations of clinical research professionals around the world. ACRP is your voice, which begins by actively listening to your shared concerns and suggestions. Stay involved and consider volunteering at the Chapter level or for a committee.
It’s been an honor to serve and work alongside our talented Executive Director, the ACRP staff, my fellow Board members, and those who volunteer their time and expertise on our numerous committees—all of whom are there to support your efforts in your essential role as part of the study team. Our collective health depends on it!
▲▼▲
In addition to his volunteer duties with ACRP, Morin provides patient care and serves as the Director of Research at Holston Medical Group, a multispecialty practice in Tennessee and Virginia, and is Director of the High-Risk Disease Prevention program for a Fortune 100 company.
